NC
DVAX

Northpointe Capital’s Dynavax Technologies DVAX Stock Holding History

Northpointe Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-539,839
Closed -$8.23M – 178
2018
Q2 		$8.23M Buy
539,839
+152,884
+40% +$2.64M 1.09% 19
2018
Q1 		$7.68M Buy
+386,955
New +$6.68M 0.96% 31

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Northpointe Capital's DVAX Position: Q3 2018 in Review

Northpointe Capital sold out of Dynavax Technologies (DVAX) in Q3 2018, closing a stake of 539,839 shares — an estimated $8.23M sold.

Northpointe Capital first reported a position in DVAX in Q1 2018 and held it in 2 quarters. The position peaked at $8.23M in Q2 2018. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • Northpointe Capital reported no remaining Dynavax Technologies position as of Q3 2018 after selling out during the quarter.
  • Northpointe Capital sold 539,839 Dynavax Technologies shares in Q3 2018, an estimated $8.23M.
  • Northpointe Capital first reported a position in Dynavax Technologies in Q1 2018 and held it in 2 quarters.
  • Northpointe Capital's Dynavax Technologies position peaked at $8.23M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on Northpointe Capital's 13F filing for Q3 2018, filed 25 Oct 2018.